Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Tumor Biology

Akt1 Induces Extracellular Matrix Invasion and Matrix Metalloproteinase-2 Activity in Mouse Mammary Epithelial Cells

Bae-Keun Park, Xiao Zeng and Robert I. Glazer
Bae-Keun Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao Zeng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert I. Glazer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published October 2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The roles of the protein-serine/threonine kinase, Akt1, in signaling pathways associated with cell motility and extracellular matrix invasion were examined in the immortalized mouse mammary epithelial cell line, COMMA-1D. COMMA-1D cells were engineered to express the avian leukosis subtype A receptor, tv-a, to permit infection by recombinant avian leukosis virus produced by the replication-competent avian splice vector, RCAS. COMMA-1D/tv-a cells transduced with RCAS/v-akt, but not RCAS/Akt1, formed anchorage-independent colonies in soft agar; however, cells overexpressing either v-akt or Akt1 became highly invasive when grown on the ECM, Matrigel. Zymography of extracellular protease activity shed into the medium by COMMA-1D/Akt1 or COMMA-1D/v-akt cells revealed elevated gelatinase activity that was confirmed to be matrix metalloproteinase-2 (MMP-2; gelatinase A) by Western blotting and immunoprecipitation-zymography. The MMP inhibitor, BB-94, blocked MMP-2 activity and invasion associated with Akt1- and v-akt-expressing cells. The proteasome inhibitor, lactacystin, markedly increased MMP-2 levels and invasion in control cells but not in Akt1- and v-akt-expressing cells. These results suggest that the invasive behavior of mammary epithelial cells induced by Akt1 is associated with increased MMP-2 expression that may result from inhibition of MMP-2 degradation by the proteasome pathway.

INTRODUCTION

The serine/threonine-protein kinase, Akt/PKB, 3 originally identified by its homology to protein kinases A and C (1 , 2) , is the transforming protein expressed by the murine AKT8 retrovirus (3 , 4) . Akt is composed of an NH2-terminal pleckstrin homology domain that binds to membrane-associated phosphatidylinositol-3,4,5-trisphosphate and phosphatidylinositol-3,4-bisphosphate generated by phosphoinositide 3-kinase (5 , 6) , a kinase catalytic domain and a COOH-terminal regulatory domain. Akt1 is one of three mammalian isoforms and is activated by several growth factor pathways that elicit phosphorylation at T308 in the activation loop of the catalytic domain and at S473 in the COOH terminus (7) . Akt1 is a downstream target of phosphoinositide 3-kinase (8) and translocates to the plasma membrane upon growth factor stimulation (9) , where it binds to phosphatidylinositol-3,4-bisphosphate and phosphatidylinositol-3,4,5-trisphosphate. This results in its activation by transphosphorylation at T308 by phosphoinositide-dependent kinase 1 (7) , and either autophosphorylation (10) or transphosphorylation at S473 by phosphoinositide-dependent kinase 1 (11 , 12) , integrin-linked kinase (13) , and protein kinase C (14) . Akt1 has been implicated in a variety of cellular functions, such as survival, transcription, and translation (8 , 15) . Overexpression of Akt blocks apoptosis in vitro and is overexpressed in ovarian, pancreatic, and breast cancer (16, 17, 18, 19) .

Cancer cell invasion through the ECM and basement membranes is mediated by degradation of collagen IV, the major structural component of the basement membrane (20) . Matrix metalloproteinases play a critical role in tumor progression, growth and metastasis (21) . The association between the activation of MMP-2 (type IV collagenase/gelatinase A) and ECM invasion in vitro constitutes a model for metastatic progression in human breast cancer (22) . Similar to other secreted MMPs, the latent proenzyme of MMP-2 is activated by its association with TIMP-2 (23 , 24) and cell surface-anchored MT1-MMP (25 , 26) , and a stoichiometric imbalance in this ternary complex may be associated with tumor progression. Overexpression of MT1-MMP induces abnormalities and tumor formation in the mammary glands of transgenic mice (27) and increases the invasiveness of prostate cancer cells (28) .

In this study, we sought to examine the role of Akt1 in the transformation and invasion of mammary epithelial cells and to determine whether these processes were controlled by the same determinants. In the course of these studies, we discovered that the induction of invasion and transformation were independent events, and that the invasive activity of Akt1-expressing cells correlated with increased MMP-2 expression and activation.

MATERIALS AND METHODS

Antibodies and Reagents.

Antibodies and reagents were obtained from the following sources: monoclonal (Ab-3) and polyclonal (Ab-7) anti-MMP-2 antibodies (Oncogene Science, Boston, MA); rabbit polyclonal anti-Akt1 antibody (06-558; Upstate Biotechnology Lake Placid, NY); mouse monoclonal anti-Akt1 antibody (610860; BD Transduction Laboratories, Lexington, KY); rhodamine-conjugated goat antirabbit IgG and Texas Red-conjugated goat antimouse IgG (KPL, Gaithersburg, MD); BB-94 (Batimastat; British Biotech, Oxford, United Kingdom); APMA (Aldrich-Sigma Chemical Co. Chemical, St. Louis, MO); and lactacystin (Calbiochem, San Diego, CA).

Cell Line Establishment and Culture.

COMMA-1D cells (29) were engineered to express the gp800 tv-a cDNA (Ref. 30 ; kindly provided by Dr. Yi Li, Memorial-Sloan Kettering Cancer Institute, New York, NY). tv-a was cloned into the pSRαMSVtkneo retroviral vector (31) and cotransfected into 293T cells with the pSV-ψ−-E-MLV ecotropic env vector by calcium phosphate precipitation. COMMA-1D cells were infected with virus-containing medium and selected in 600 μg/ml G418 for 2 weeks. The expression and the proper function of tv-a in G418-selected COMMA-1D cells were confirmed by immunostaining with a rabbit polyclonal anti-tv-a antibody (generously provided by Dr. Andrew Leavitt, University of California, San Francisco, CA) and by transduction with a recombinant ALV encoding the GFP gene (see below). High-titer ALV was generated by transfecting DF-1 chicken embryo fibroblast cells (Ref. 32 ; kindly provided by Dr. Stephen Hughes, National Cancer Institute, Bethesda, MD) growing in DMEM containing 10% FCS, 10% tryptose phosphate broth, and 1% chicken serum, with ALV generated with RCAS/Akt1 and RCAS/v-akt (Ref. 33 ; generously provided by Drs. Peter Vogt and Masahiro Aoki, The Scripps Research Institute, La Jolla, CA) using calcium phosphate precipitation (34) . After 6 days, the medium was centrifuged at 3000 × g for 5 min, and the virus-containing supernatant was added to COMMA-1D/tv-a cells and incubated overnight. Cells were transduced by three sequential rounds of infection over 2 days. The medium was then aspirated, and the COMMA-1D/tv-a cell lines were cultured as monolayers in IMEM containing 2.5% FCS, epidermal growth factor (Upstate Biotechnology, Lake Placid, NY; 10 ng/ml), and insulin (Aldrich-Sigma Chemical Co., St. Louis, MO; 5 μg/ml).

Anchorage-independent Growth.

COMMA-1D/Akt1 or COMMA-1D/v-akt cells (1 × 105) were suspended in 2 ml of 0.5% (wt/vol) SeaPrep agar (BMA, Rockland, ME) dissolved in IMEM containing 10% FCS and gentamicin (50 μg/ml) and overlaid on 1% agar dissolved in IMEM containing 2% FCS in six-well plates. Cultures were fed once a week for 5 weeks.

Akt Kinase Assay.

A rabbit polyclonal Akt1 antibody (Upstate Biotechnology) was adsorbed on 50 μl of protein A/G-agarose (Santa Cruz Biotechnology, Santa Cruz, CA), and incubated with 250 μg of cell lysate. Immunoprecipitates were incubated in 30 μl of kinase buffer containing 10 μCi of [γ-32P]ATP, 5 μm ATP, 75 mm MgCl2, 20 mm 4-morpholinepropanesulfonic acid (pH 7.2), 25 mm β-glycerol phosphate (pH 7.0), 1 mm Na3VO4, 1 mm DTT, 17 μm protein kinase A inhibitor peptide, and 30 μm histone H2B as substrate (16) . The relative amounts of incorporated radioactivity were determined by autoradiography and densitometry.

Preparation of Samples from Conditioned Media.

Monolayer cultures were grown in 75-cm2 plastic flasks for 48 h, washed three times with PBS, and then incubated for 18 h in serum-free IMEM. The medium was collected and concentrated using a Centricon 10 centrifugal filter with a Mr 3000 cutoff (Amicon, Bedford, MA).

Western Blotting Analysis.

Whole cell lysates were prepared by lysing cells in a buffer containing 50 mm Tris-HCl (pH 7.4), 1% NP40, 150 mm NaCl, 1 mm EGTA, 1 mm phenylmethylsulfonyl fluoride, 1 mm Na3VO4, 1 mm NaF and Complete protease inhibitor cocktail (Boehringer Mannheim, Mannheim, Germany). Lysates (20 μg of protein) were mixed with Laemmli sample buffer, boiled for 5 min, and separated in 10% PAGEr Gold precast gels (BMA, Rockland, ME) by SDS-PAGE. Resolved proteins were electrophoretically transferred to a nitrocellulose membrane (Protran; Schleicher & Schuell, Keene, NH) and blocked for 1 h in 5% nonfat dry milk in TBST buffer [10 mm Tris-HCl (pH 7.2), 50 mm NaCl, and 0.2% Tween 20]. Blots were incubated overnight with primary antibody at 4°C and then for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibody diluted 1:5000. Labeled proteins were visualized with the ECL detection system (Amersham, Arlington Heights, IL) according to the manufacturer’s instructions.

Matrigel Invasion Assay.

Assays were carried out with untreated cells or cells treated overnight with either 100 nm BB-94 or 1 μm lactacystin. Cells were then plated on Matrigel-coated Biocoat Cell Culture Insert chambers (Becton Dickinson Labware, Bedford, MA) containing 23-mm diameter, 8-μm pore size filters. Matrigel was diluted with cold, serum-free IMEM and 850 μg of Matrigel were applied to each filter, dried in a hood, and incubated at 37°C for 30 min. Cells (1 × 105) were suspended in serum-free IMEM and added to the Matrigel-coated chamber, and conditioned medium was placed in the lower chamber as a chemoattractant. After incubation for 72 h at 37°C in 5% CO2, the Matrigel-coated side of the filter was removed with a cotton swab, and cells on the opposite side of the filter were fixed in 10% formaldehyde, stained with H&E, and counted. Each assay was performed in triplicate.

Gelatin Zymography.

Two μg of protein from concentrated cell-conditioned medium were loaded onto 10% acrylamide-0.1% gelatin gels (Novex, San Diego, CA) and separated by electrophoresis under nonreducing conditions. After electrophoresis, gels were renatured by soaking for 30 min at room temperature in 2.5% Triton X-100 with gentle agitation. Zymogram gels were then equilibrated for 30 min at room temperature in developing buffer [50 mm Tris, 40 mm HCl (pH 7.4), 200 mm NaCl, 5 mm CaCl2, and 0.02% Brij35] and incubated overnight at 37°C. Transparent bands of gelatinolytic activity were visualized by staining with 0.5% Coomassie Blue R250.

Immunocytofluorescence.

Invasion assays were performed as described above, and after 60 h, attached cells were fixed for 30 min at 4°C with 2% paraformaldehyde and blocked for 30 min at room temperature in 10% normal goat serum, 1% gelatin in PBS. Cells attached to Matrigel were incubated for 2 h at room temperature with a polyclonal anti-MMP-2 antibody diluted 1:100 in blocking buffer and washed for 5 min with PBS three times. The sections were stained for 1 h with rhodamine-conjugated goat antirabbit IgG diluted 1:200, followed by washing with PBS.

For subcellular localization of Akt, chamber-mounted glass slides (Nalge Nunc International, Naperville, IL) were coated with a concentrated cell suspension and fixed for 10 min at room temperature by addition of an equal volume of 10% formaldehyde to the growth medium. The supernatant was removed, and cells were permeabilized with 0.05% Triton X-100 in PBS. Slides were washed with PBS three times and blocked for 1 h at room temperature with 20% goat serum in PBS. Cells were incubated for 1 h at room temperature with a monoclonal anti-Akt1 antibody diluted 1:100 in 20% goat serum/PBS. Slides were washed with PBS three times and then incubated for 1 h with Texas Red-conjugated goat antimouse antibody diluted 1:200, followed by washing with PBS. Slides were treated with ProLong Antifade reagent (Molecular Probes, Inc.), and stained sections were visualized by confocal microscopy.

RESULTS

Transduction of Mammary Epithelial Cells by Recombinant ALV.

To examine gene expression in mammary epithelial cells, COMMA-1D cells were engineered to express the ALV subtype A receptor, tv-a, to make them permissive to infection by RCAS viruses. COMMA-1D/tv-a cells were then transduced with RCAS/GFP to allow selection by FACS (Fig. 1) ⇓ . A single clone sorted from the high tv-a-expressing cells was expanded and used in all subsequent studies.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Selection of COMMA-1D/tv-a cells. COMMA-1D/tv-a cells were transduced with RCAS-GFP and sorted by FACS. Fluorescence microscopy of COMMA-1D (A) and COMMA-1D/tv-a (B) cells expressing GFP is shown. ×100. C, FACS analysis of COMMA-1D and COMMA-1D/tv-a cells expressing GFP.

Anchorage-independent Growth and Invasion.

COMMA-1D cells transduced with RCAS-Akt1, and particularly RCAS–v-akt, exhibited high kinase activity compared with the parental cell line expressing GFP alone, as measured by immune-complex kinase assay (Fig. 2) ⇓ . To measure transformation potential, anchorage-independent growth of these cell lines in soft agar was determined (Fig. 3A) ⇓ . After 5 weeks in culture, cells transduced with v-akt, but not Akt1, formed colonies, which appeared as early as 1 week after infection.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Akt kinase activity in COMMA-1D/Akt1 and COMMA-1D/v-akt cells. Immunocomplex kinase assays were carried out using histone H2B as substrate, and incorporated radioactivity was determined by autoradiography and densitometry. Each value is the mean of duplicate results from two experiments; bars, SD.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Anchorage-independent growth and Matrigel invasion activity of COMMA-1D/Akt1 and COMMA-1D/v-akt cells. A, anchorage-independent growth in soft agar. Colony formation was measured 3 weeks after plating. Each value is the mean of three experiments; bars, SD. B, ECM invasion was measured in a modified Boyden chamber with Matrigel-coated filters as described in “Materials and Methods.” The number of cells migrating to the underside of the filter was measured after 72 h and is expressed as a percentage of the number of cells applied to the filter. MDA-MB-231 breast carcinoma cells were used as a positive control. Each value is the mean of three experiments; bars, SD.

To determine whether these cells also possessed invasive potential, Boyden chamber assays were performed with Matrigel as a substrate (Fig. 3B) ⇓ . Both COMMA-1D/Akt1 and COMMA-1D/v-akt cells exhibited 25–30% of the invasive potential of MDA-MB-231 breast carcinoma cells, in contrast to parental cells, which were not invasive.

No morphological differences were observed between control and Akt-transduced cells when grown on a plastic substratum (Fig. 4, A, C, and E) ⇓ ; however, when cells were grown for 72 h on Matrigel, COMMA-1D/tv-a cells formed simple, spherical colonies (Fig. 4B) ⇓ , in contrast to the more dense and branched lattices of cells formed by the Akt1- and v-akt-transduced cells (Fig. 4, D and F) ⇓ .

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Light microscopy of COMMA-1D/Akt1 and COMMA-1D/v-akt cells growing on plastic or Matrigel. A and B, COMMA-1D/tv-a cells; C and D, COMMA-1D/Akt1 cells; E and F, COMMA-1D/v-akt cells grown on plastic (A, C, and E) or Matrigel (B, D, and F). ×100.

Akt1 Induces MMP-2 Activity.

To determine whether secreted protease activity was associated with invasion activity, cell-conditioned medium was assayed by gelatin zymography (Fig. 5) ⇓ . Several bands of activity were revealed under nondenaturing, nonreducing conditions (Fig. 5A) ⇓ , and immunoblotting of the concentrated cell-conditioned medium from COMMA-1D/Akt1 and COMMA-1D/v-akt cells indicated the presence of an Mr 85,000 form of MMP-2 (Fig. 5B) ⇓ , the activity of which was confirmed by immunoprecipitation and gelatin zymography (Fig. 5C) ⇓ . To determine whether the Mr 85,000 form of MMP-2 was proMMP-2, samples were incubated with the cysteine-modifying agent, APMA, to induce autocatalysis (Fig. 6A) ⇓ . APMA induced the autocatalytic processing of Mr 85,000 MMP-2 to Mr 50,000–72,000 species, suggesting that the high molecular weight MMP-2 complex consisted predominantly of proMMP-2.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

MMP-2 activity associated with the conditioned medium from COMMA-1D/Akt1 and COMMA-1D/v-akt cells. A, gelatin zymography of proteolytic activity in the conditioned medium. Lane 1, COMMA-1D/tv-a; Lane 2, COMMA-1D/Akt1; Lane 3, COMMA-1D/v-akt cells. Ordinate, the position of prestained protein markers in thousands. B, immunoblot of the conditioned medium used for gelatinase assays in A. Ordinate, the position of prestained protein markers in thousands. C, MMP-2 immunoprecipitation-gelatinase assay using the conditioned medium in A. Lane 1, COMMA-1D/tv-a; Lane 2, COMMA-1D/Akt1; Lane 3, COMMA-1D/v-akt cells; Lane 4, recombinant MMP-2. Ordinate, the position of prestained protein markers.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Gelatinase and invasion activity of COMMA-1D/Akt1 cells treated with APMA or BB-94. A, conditioned medium from COMMA-1D/Akt1 cells was treated in vitro with 1 mm APMA prior to zymography. Lane 1, conditioned medium from COMMA-1D/tv-a cells; Lane 2, untreated COMMA-1D/Akt1 cells; Lane 3, APMA-treated COMMA-1D/Akt1. Arrows, active forms of MMP-2 resulting from APMA-induced autocatalysis of proMMP-2. Ordinate, the position of prestained protein markers in thousands. B, cells were treated for 24 h with 100 nm BB-94, and the conditioned medium was concentrated and tested for gelatinase activity as described in “Materials and Methods.” Lane 1, conditioned medium from COMMA-1D/tv-a cells; Lane 2, control COMMA-1D/Akt1 cells; Lane 3, COMMA-1D/Akt1 cells treated with BB-94. Ordinate, the position of prestained protein markers in thousands. C, cells were treated as in B, and Matrigel invasion assays were carried out as described in Fig. 3B ⇓ . Each value is the mean of triplicate determinations; bars, SD.

To further characterize MMP-2 activity, conditioned medium from Akt-transduced cells was incubated with the pan MMP inhibitor, BB-94 (Fig. 6B) ⇓ . BB-94 inhibited the gelatinolytic activity of the Mr ∼85,000 form as well as lower molecular weight forms of MMP-2. Treatment of COMMA-1D/Akt1 and COMMA-1D/v-akt cells for 24 h with 100 nm BB-94, a noncytotoxic concentration, inhibited Matrigel invasion by 70% (Fig. 6C) ⇓ , suggesting a causal relationship between MMP-2 expression and invasion.

Immunolocalization of MMP-2 and Akt1.

To determine whether MMP-2 was localized to the cell surface, MMP-2 expression was measured in COMMA-1D/Akt1 cells by immunohistochemical staining (Fig. 7A) ⇓ . MMP-2 was present in cell aggregates growing on Matrigel (Fig. 7A ⇓ , left panel) but was barely visible in control cells (Fig. 7A ⇓ , left panel). Immunohistochemical staining for Akt1 and v-akt indicated that both enzymes were concentrated in the plasma membrane and cytosol to the same degree (Fig. 7B) ⇓ .

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

Confocal microscopy of COMMA-1D/tv-a and COMMA-1D/Akt1 cells immunostained for MMP-2, Akt1 and v-akt. A, cells were grown for 60 h on Matrigel and stained for MMP-2 using a polyclonal MMP-2 antibody and a rhodamine-conjugated secondary antibody. Confocal immunofluorescence (left panel) or phase contrast microscopy (right panel) is shown. ×400. B, cells were grown as described in A, except that they were stained using a monoclonal Akt1 antibody and a Texas Red-conjugated secondary antibody. ×600.

Posttranslational Regulation of MMP-2 Expression.

One mechanism by which Akt might regulate MMP-2 expression is by the modulation of proteasome activity either indirectly though GSK-3β inhibition (35 , 36) or directly through MMP-2 phosphorylation. Therefore, cells were treated for 24 h with 1 μm lactacystin, a noncytotoxic concentration, and MMP-2 levels in the conditioned medium were determined (Fig. 8A) ⇓ . Lactacystin treatment dramatically increased MMP-2 levels in control cells but had only a marginal effect on MMP-2 levels in Akt1- and v-akt-transduced cells. Treatment of COMMA-1D/tv-a cells with lactacystin also resulted in a dramatic increase in their invasive activity but only a slight increase in the activity of COMMA-1D/Akt1 and COMMA-1D/v-akt cells (Fig. 8B) ⇓ .

Fig. 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 8.

Effect of lactacystin treatment on MMP-2 expression. A, cells were treated for 18 h with 1 μm lactacystin, and the conditioned medium was concentrated, separated by SDS-PAGE, and transferred to nitrocellulose. MMP-2 was detected by immunoblotting using a polyclonal MMP-2 antibody. Each lane contains 20 μg of protein. B, cells were treated for 24 h with 1 μm lactacystin, and Matrigel invasion assays were carried out as described in Fig. 3B ⇓ . Each value is the mean of duplicate determinations; bars, SD.

DISCUSSION

The present study has examined the ability of Akt1 and its oncogenic homologue, v-akt, to activate ECM invasion in mouse mammary epithelial cells. To achieve this objective, we developed a cell line that is amenable to transduction by one or more recombinant avian retroviruses (37) . This system is based on the introduction of the ALV subtype A receptor, tv-a, into mammalian cells making them permissive to infection by recombinant ALV (38) . The mouse mammary epithelial cell line, COMMA-1D, was used for this retrovirus delivery system because these cells have been shown to differentiate in vitro and to give rise to normal gland structures in the cleared fat pad of the BALB/c mouse (39 , 40) . Although these immortalized mammary epithelial cells contain one mutated p53 allele (41) , they do not exhibit a transformed phenotype either in vitro or in vivo (39 , 40) .

Transduction of COMMA-1D/tv-a cells with Akt1 or v-akt led to an interesting dichotomy between their ability to induce transformation versus their ability to induce invasion. Although it is believed that the constitutive activity and plasma membrane localization of v-akt are responsible for its oncogenic activity (3 , 33 , 42) , mammary epithelial cells were found to be susceptible to transformation by v-akt, but not by Akt1, despite little difference in membrane localization of these proteins (Fig. 7B) ⇓ ; however, v-akt did exhibit 2.5-fold greater activity, which may account, in part, for its transforming activity. Because v-akt and Akt1 induced similar invasion activity and MMP-2 expression, differences other than absolute activity and membrane localization appear to be associated with MMP-2 expression. One clue to the mechanism for this effect may be deduced from the lactacystin experiments. Control cells treated with this proteasome inhibitor exhibited a dramatic increase in MMP-2 levels and invasion activity in comparison with its marginal effect on Akt- and v-akt-expressing cells. This suggests that the mechanism of action of Akt1 and v-akt is similar to that of lactacystin, i.e., to block proteasome activity. This effect may occur indirectly though GSK-3β inhibition by Akt (35 , 36) or directly through MMP-2 phosphorylation, although the latter possibility has not been reported.

Another way by which Akt may increase MMP-2 expression is by transcriptional activation. The MMP-2 promoter contains several cis-acting regulatory elements including cyclic AMP-responsive element binding, Sp1, Ets-1 and AP-2 (43) . Akt is known to up-regulate ets-2 (44) and cyclic AMP-responsive element binding (45) , and we are currently examining whether this is a potential regulatory pathway for MMP-2 expression by Akt1 in mammary epithelial cells.

ECM invasion depends on the cooperative processes of cell adhesion and membrane-associated proteolysis (46) . MMP-2 has been implicated in ECM invasion in breast carcinoma cell lines (47, 48, 49) as well as in mammary epithelial cells transduced with H-Ras or stimulated by nitric oxide activators (50 , 51) . Invasion correlated with phosphoinositide 3-kinase and Akt activation in instances where ECM invasion was induced by epidermal growth factor or IGF-1 (52 , 53) . Akt activation has also been implicated in ECM adhesion and H-Ras-mediated transformation by blocking anoikis-induced cell death (54 , 55) , and Akt has been shown to localize to sites of epithelial cell-matrix contact (56) . MMP-2 localizes to the surface of invading tumor and endothelial cells and interacts through its COOH-terminal hemopexin-like domain with αvβ3 integrin (57, 58, 59) . Cleavage of the ECM by MMP-2 induces migratory activity of breast epithelial cells (60) , suggesting a close relationship between cell adhesion and cell invasion in tissue remodeling. Because αvβ3-mediated cell migration in tumor cells was dependent on Akt activation (61) , Akt and MMP-2 appear to be critically linked to cell adhesion.

MMP-2 exists as a Mr 100,000 complex of proMMP-2 and TIMP-2, which results in multiple forms of secreted MMP-2 (23) . Incubation of this complex with the cysteine-reactive compound, APMA, promoted the autocatalytic processing of proMMP-2 to active Mr 72,000 to Mr 50,000 species (Fig. 6B ⇓ ; Refs. 23 , 24 , 62 ). On the cell surface, proMMP-2 is activated by MT1-MMP after its association with TIMP-2 via its hemopexin domain (63) . Formation of a complex of proMMP-2 with MT1-MMP correlated with ECM invasion where the complex localizes to invadopodia (64) and to sites of collagenolytic activity (25) . Although MT1-MMP-dependent invasion was independent of proMMP-2 activation, both enzymes were required to be membrane-anchored to the cell surface to function as pericellular collagenases (25) . Therefore, these studies suggest that the concentration of MMP-2 along basement membranes at sites of tissue remodeling and at the leading edge of invading cells (65 , 66) is a major factor contributing to tumor progression and invasion (67, 68, 69) . The present study further delineates that the Akt1 signaling pathway is involved in up-regulating this process and suggests a mechanism by which tumors with high Akt1 expression may be more invasive and metastatic.

Acknowledgments

We thank Drs. Peter Vogt and Masahiro Aoki (Scripps Research Institute) for providing RCAS/Akt1 and RCAS/v-akt, Dr. Stephen Hughes (National Cancer Institute) for providing the RCAS vector and DF-1 cells, Dr. Yi Li (Memorial Sloan-Kettering Cancer Institute) for providing the tv-a cDNA, and Dr. Andrew Leavitt (University of California, San Francisco, CA) for providing the polyclonal anti-tv-a antibody.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 Supported by National Cancer Institute Grant CA81565 and Department of Defense Grant DAMD17-99-1-9195.

  • ↵2 To whom requests for reprints should be addressed, at Georgetown University School of Medicine, 3970 Reservoir Road, NW, Research Building, Room W318, Washington, DC 20007. Phone: (202) 687-8324; Fax: (202) 687-7505; E-mail: glazerr{at}georgetown.edu

  • ↵3 The abbreviations used are: Akt/PKB, Akt/protein kinase B; ALV, avian leukosis virus; ECM, extracellular matrix; FACS, fluorescence-activated cell sorting; GFP, green fluorescent protein; MMP-2, matrix metalloproteinase-2; MT1-MMP, membrane-type 1 matrix metalloproteinase; RCAS, replication-competent avian splice vector; TIMP, tissue inhibitor of metalloproteinase; tv-a, avian leukosis subtype A receptor; APMA, 4-aminophenylmercuric acetate.

  • Received May 4, 2001.
  • Accepted August 16, 2001.
  • ©2001 American Association for Cancer Research.

References

  1. ↵
    Coffer P. J., Woodgett J. R. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur. J. Biochem., 201: 475-481, 1991.
    OpenUrlCrossRefPubMed
  2. ↵
    Jones P. F., Jakubowicz T., Pitossi F. J., Maurer F., Hemmings B. A. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc. Natl. Acad. Sci. USA, 88: 4171-4175, 1991.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Bellacosa A., Testa J. R., Staal S. P., Tsichlis P. N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (Wash. DC), 254: 274-277, 1991.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Staal S. P., Hartley J. W., Rowe W. P. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci. USA, 74: 3065-3067, 1977.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    James S. R., Downes C. P., Gigg R., Grove S. J., Holmes A. B., Alessi D. R. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem. J., 315: 709-713, 1996.
  6. ↵
    Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G. F., Holmes A. B., Gaffney P. R., Reese C. B., McCormick F., Tempst P., Coadwell J., Hawkins P. T. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5- trisphosphate-dependent activation of protein kinase B. Science (Wash DC), 279: 710-714, 1998.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15: 6541-6551, 1996.
    OpenUrlPubMed
  8. ↵
    Franke T. F., Kaplan D. R., Cantley L. C. PI3K: downstream AKTion blocks apoptosis. Cell, 88: 435-437, 1997.
    OpenUrlCrossRefPubMed
  9. ↵
    Andjelkovic M., Alessi D. R., Meier R., Fernandez A., Lamb N. J., Frech M., Cron P., Cohen P., Lucocq J. M., Hemmings B. A. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem., 272: 31515-31524, 1997.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Toker A., Newton A. C. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem., 275: 8271-8274, 2000.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C. P., Alessi D. R. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol., 9: 393-404, 1999.
    OpenUrlCrossRefPubMed
  12. ↵
    Williams M. R., Arthur J. S., Balendran A., van der Kaay J., Poli V., Cohen P., Alessi D. R. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol., 10: 439-448, 2000.
    OpenUrlCrossRefPubMed
  13. ↵
    Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA, 95: 11211-11216, 1998.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Li W., Zhang J., Flechner L., Hyun T., Yam A., Franke T. F., Pierce J. H. Protein kinase C-α overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene, 18: 6564-6572, 1999.
    OpenUrlCrossRefPubMed
  15. ↵
    Chan T. O., Rittenhouse S. E., Tsichlis P. N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem., 68: 965-1014, 1999.
    OpenUrlCrossRefPubMed
  16. ↵
    Ahmad S., Singh N., Glazer R. I. Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGF- I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem. Pharmacol., 58: 425-430, 1999.
    OpenUrlCrossRefPubMed
  17. ↵
    Bellacosa A., de Feo D., Godwin A. K., Bell D. W., Cheng J. Q., Altomare D. A., Wan M., Dubeau L., Scambia G., Masciullo V., et al Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer, 64: 280-285, 1995.
    OpenUrlCrossRefPubMed
  18. ↵
    Liu W., Li J., Roth R. A. Heregulin regulation of Akt/protein kinase B in breast cancer cells. Biochem. Biophys. Res. Commun., 261: 897-903, 1999.
    OpenUrlCrossRefPubMed
  19. ↵
    Dufourny B., Alblas J., van Teeffelen H. A., van Schaik F. M., van der Burg B., Steenbergh P. H., Sussenbach J. S. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem., 272: 31163-31171, 1997.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Timpl R., Rohde H., Robey P. G., Rennard S. I., Foidart J. M., Martin G. R. Laminin–a glycoprotein from basement membranes. J. Biol. Chem., 254: 9933-9937, 1979.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Stetler-Stevenson W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9: 289-303, 1990.
    OpenUrlCrossRefPubMed
  22. ↵
    Gilles C., Bassuk J. A., Pulyaeva H., Sage E. H., Foidart J. M., Thompson E. W. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res., 58: 5529-5536, 1998.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Fridman R., Fuerst T. R., Bird R. E., Hoyhtya M., Oelkuct M., Kraus S., Komarek D., Liotta L. A., Berman M. L., Stetler-Stevenson W. G. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. Biol. Chem., 267: 15398-15405, 1992.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Howard E. W., Bullen E. C., Banda M. J. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J. Biol. Chem., 266: 13064-13069, 1991.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Hotary K., Allen E., Punturieri A., Yana I., Weiss S. J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol., 149: 1309-1323, 2000.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Kurschat P., Zigrino P., Nischt R., Breitkopf K., Steurer P., Klein C. E., Krieg T., Mauch C. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J. Biol. Chem., 274: 21056-21062, 1999.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Ha Y. Y., Moon H. B., Nam M. S., Lee J. W., Ryoo Z. Y., Lee T. H., Lee K. K., So B. J., Sato H., Seiki M., Yu D. Y. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res., 61: 984-990, 2001.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Nagakawa O., Murakami K., Yamaura T., Fujiuchi Y., Murata J., Fuse H., Saiki I. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines. Cancer Lett., 155: 173-179, 2000.
    OpenUrlCrossRefPubMed
  29. ↵
    Kittrell F. S., Oborn C. J., Medina D. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res., 52: 1924-1932, 1992.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Bates P., Young J. A., Varmus H. E. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell, 74: 1043-1051, 1993.
    OpenUrlCrossRefPubMed
  31. ↵
    Muller A. J., Young J. C., Pendergast A. M., Pondel M., Landau N. R., Littman D. R., Witte O. N. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol., 11: 1785-1792, 1991.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Schaefer-Klein J., Givol I., Barsov E. V., Whitcomb J. M., VanBrocklin M., Foster D. N., Federspiel M. J., Hughes S. H. The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology, 248: 305-311, 1998.
    OpenUrlCrossRefPubMed
  33. ↵
    Aoki M., Batista O., Bellacosa A., Tsichlis P., Vogt P. K. The akt kinase: molecular determinants of oncogenicity. Proc. Natl. Acad. Sci. USA, 95: 14950-14955, 1998.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Barsov E. V., Hughes S. H. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus. J. Virol., 70: 3922-3929, 1996.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Shaw M., Cohen P., Alessi D. R. Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett., 416: 307-311, 1997.
    OpenUrlCrossRefPubMed
  36. ↵
    Diehl J. A., Cheng M., Roussel M. F., Sherr C. J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev., 12: 3499-3511, 1998.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Federspiel M. J., Hughes S. H. Retroviral gene delivery. Methods Cell Biol., 52: 179-214, 1997.
    OpenUrlPubMed
  38. ↵
    Federspiel M. J., Bates P., Young J. A., Varmus H. E., Hughes S. H. A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc. Natl. Acad. Sci. USA, 91: 11241-11245, 1994.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Danielson K. G., Oborn C. J., Durban E. M., Butel J. S., Medina D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc. Natl. Acad. Sci. USA, 81: 3756-3760, 1984.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Aguilar-Cordova E., Strange R., Young L. J., Billy H. T., Gumerlock P. H., Cardiff R. D. Viral Ha-ras mediated mammary tumor progression. Oncogene, 6: 1601-1607, 1991.
    OpenUrlPubMed
  41. ↵
    Wolff J., Wong C., Cheng H., Poyet P., Butel J. S., Rosen J. M. Differential effects of the simian virus 40 early genes on mammary epithelial cell growth, morphology, and gene expression. Exp. Cell Res., 202: 67-76, 1992.
    OpenUrlCrossRefPubMed
  42. ↵
    Ahmed N. N., Franke T. F., Bellacosa A., Datta K., Gonzalez-Portal M. E., Taguchi T., Testa J. R., Tsichlis P. N. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene, 8: 1957-1963, 1993.
    OpenUrlPubMed
  43. ↵
    Qin H., Sun Y., Benveniste E. N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem., 274: 29130-29137, 1999.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Smith J. L., Schaffner A. E., Hofmeister J. K., Hartman M., Wei G., Forsthoefel D., Hume D. A., Ostrowski M. C. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Mol. Cell. Biol., 20: 8026-8034, 2000.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Du K., Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem., 273: 32377-32379, 1998.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Quaranta V. Cell migration through extracellular matrix: membrane-type metalloproteinases make the way. J. Cell Biol., 149: 1167-1170, 2000.
    OpenUrlFREE Full Text
  47. ↵
    Azzam H. S., Arand G., Lippman M. E., Thompson E. W. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst. (Bethesda), 85: 1758-1764, 1993.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Deryugina E. I., Luo G. X., Reisfeld R. A., Bourdon M. A., Strongin A. Tumor cell invasion through Matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res., 17: 3201-3210, 1997.
    OpenUrlPubMed
  49. ↵
    Bemis L. T., Schedin P. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res., 60: 3414-3418, 2000.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Moon A., Kim M. S., Kim T. G., Kim S. H., Kim H. E., Chen Y. Q., Kim H. R. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer, 85: 176-181, 2000.
    OpenUrlCrossRefPubMed
  51. ↵
    Orucevic A., Bechberger J., Green A. M., Shapiro R. A., Billiar T. R., Lala P. K. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int. J. Cancer, 81: 889-896, 1999.
    OpenUrlCrossRefPubMed
  52. ↵
    Price J. T., Tiganis T., Agarwal A., Djakiew D., Thompson E. W. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res., 59: 5475-5478, 1999.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Tanno S., Mitsuuchi Y., Altomare D. A., Xiao G. H., Testa J. R. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res., 61: 589-593, 2001.
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P. H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16: 2783-2793, 1997.
    OpenUrlAbstract
  55. ↵
    Rytomaa M., Lehmann K., Downward J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene, 19: 4461-4468, 2000.
    OpenUrlCrossRefPubMed
  56. ↵
    Watton S. J., Downward J. Akt/PKB localization and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol., 9: 433-436, 1999.
    OpenUrlCrossRefPubMed
  57. ↵
    Brooks P. C., Stromblad S., Sanders L. C., von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., Quigley J. P., Cheresh D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85: 683-693, 1996.
    OpenUrlCrossRefPubMed
  58. ↵
    Brooks P. C., Silletti S., von Schalscha T. L., Friedlander M., Cheresh D. A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell, 92: 391-400, 1998.
    OpenUrlCrossRefPubMed
  59. ↵
    Yan L., Moses M. A., Huang S., Ingber D. E. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J. Cell Sci., 113: 3979-3987, 2000.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W. G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (Wash. DC), 277: 225-228, 1997.
    OpenUrlAbstract/FREE Full Text
  61. ↵
    Zheng D. Q., Woodard A. S., Tallini G., Languino L. R. Substrate specificity of αvβ3 integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J. Biol. Chem., 275: 24565-24574, 2000.
    OpenUrlAbstract/FREE Full Text
  62. ↵
    Stricklin G. P., Jeffrey J. J., Roswit W. T., Eisen A. Z. Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry, 22: 61-68, 1983.
    OpenUrlCrossRefPubMed
  63. ↵
    Overall C. M., Tam E., McQuibban G. A., Morrison C., Wallon U. M., Bigg H. F., King A. E., Roberts C. R. Domain interactions in the gelatinase A, TIMP-2, MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. J. Biol. Chem., 275: 39497-39506, 2000.
    OpenUrlAbstract/FREE Full Text
  64. ↵
    Nakahara H., Howard L., Thompson E. W., Sato H., Seiki M., Yeh Y., Chen W. T. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA, 94: 7959-7964, 1997.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    Monsky W. L., Kelly T., Lin C. Y., Yeh Y., Stetler-Stevenson W. G., Mueller S. C., Chen W. T. Binding and localization of Mr 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res., 53: 3159-3164, 1993.
    OpenUrlAbstract/FREE Full Text
  66. ↵
    Nabeshima K., Inoue T., Shimao Y., Okada Y., Itoh Y., Seiki M., Koono M. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Res., 60: 3364-3369, 2000.
    OpenUrlAbstract/FREE Full Text
  67. ↵
    Baumann P., Zigrino P., Mauch C., Breitkreutz D., Nischt R. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Br. J. Cancer, 83: 1387-1393, 2000.
    OpenUrlCrossRefPubMed
  68. ↵
    Dolo V., D’Ascenzo S., Violini S., Pompucci L., Festuccia C., Ginestra A., Vittorelli M. L., Canevari S., Pavan A. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis, 17: 131-140, 1999.
    OpenUrlCrossRefPubMed
  69. ↵
    Ellenrieder V., Alber B., Lacher U., Hendler S. F., Menke A., Boeck W., Wagner M., Wilda M., Friess H., Buchler M., Adler G., Gress T. M. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer, 85: 14-20, 2000.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Cancer Research: 61 (20)
October 2001
Volume 61, Issue 20
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Akt1 Induces Extracellular Matrix Invasion and Matrix Metalloproteinase-2 Activity in Mouse Mammary Epithelial Cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Akt1 Induces Extracellular Matrix Invasion and Matrix Metalloproteinase-2 Activity in Mouse Mammary Epithelial Cells
Bae-Keun Park, Xiao Zeng and Robert I. Glazer
Cancer Res October 15 2001 (61) (20) 7647-7653;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Akt1 Induces Extracellular Matrix Invasion and Matrix Metalloproteinase-2 Activity in Mouse Mammary Epithelial Cells
Bae-Keun Park, Xiao Zeng and Robert I. Glazer
Cancer Res October 15 2001 (61) (20) 7647-7653;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Abstract 6119: RNAi rat models for drug discovery
  • Abstract 3834: Histone methyltransferase SET8 is regulated by miR-192/-215 and induces oncogene-induced senescence via p53-dependent DNA damage in human gastric carcinoma cells
  • Abstract 3788: CircHMGCS1 interacts with RNA binding protein HuR and maintains stem-like cells in gliomas
Show more Tumor Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement